Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • LRRK2 Role in Idiopathic Parkinson's Disease, 2014
    Use of Lrrk2-associated Cellular Fingerprints to Link Familial Forms to Idiopathic Forms of Parkinson’s Disease

    Objective/Rationale:             
    Clinical and genetic findings have established a clear link between the LRRR2 gene and Parkinson’s disease. To what extent and by what mechanisms LRRK2 contributes to...

  • Research Grant, 2014
    Direct Reprogramming of Functional, Induced Dopaminergic Neurons from Human Adult Somatic Cells

    Promising Outcomes of Original Grant:
    We have established a new procedure to directly convert skin fibroblasts (a type of cell) from pre-clinical models into induced dopaminergic (iDA) neurons. We have...

  • Rapid Response Innovation Awards, 2014
    Rating Segmental Progression of Cardinal Motor Symptoms in Early Parkinson's Disease

    Objective/Rationale: 
    We recently reported a new, practical approach to rate segmental progression of cardinal motor symptoms in Parkinson's disease (PD) at early stages. We computed four new scores —...

  • Access to Data and Biospecimens, 2014
    Contribution of the Unfolded Protein Response to Idiopathic and LRRK2-driven Parkinson’s Disease

    Objective/Rationale:             
    The unfolded protein response (UPR) is a life-death switch that instructs aged and overworked cells to self-destruct. We hypothesize that hyper-activation of the UPR...

  • Research Grant, 2014
    Role of LRRK2 in Alpha-synuclein-induced Neurodegeneration: Supplement

    Promising Outcomes of Original Grant:
    We seek to develop a robust and standardized pre-clinical model relevant to late-onset Parkinson’s disease (PD) that will identify clinically viable LRRK2 kinase...

  • Rapid Response Innovation Awards, 2014
    Integrative Genomic Approach to Discover Disease Mechanisms Underlying Parkinson’s Disease

    Objective/Rationale:             
    Complex diseases such as Parkinson’s are caused by a combination of genetic, environmental and lifestyle factors that all lead to different causal regulation...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.